Abstract
The use of artificial lipid bilayers in the form of vesicles has been described as an efficient means of presenting antigens (1, 2 and Chapter 9). A large variety of natural phospholipids or other polar amphiphiles can be used in an aqueous solution of an antigen to form either unilamellar or multilamellar spherules. The antigen(s) may either be lipid-soluble and insert into the artificial lipid bilayer, bmd to the bilayer, or become entrapped inside the spherule. In the multilamellar liposomes the antigen(s) may also be trapped in the aqueous compartments between the lipid bilayers. The surface of the liposome may also be positively or negatively charged by the addition of suitable charged amphiphiles. Many of the natural adjuvant substances are amphiphilic and may insert into the lipo-some through hydrophobic groups (3, 4). It has been my experience that the purity of the phosphohpid does affect the stability of the final preparation of liposomes and their leakiness. For instance, Gregoriadis (1) points out that plasma high-density lipoproteins will remove low-melting phospholipids from liposomes and cause leakiness. With high-melting phospholipids or with an excess of cholesterol, the lipid bilayers become rigid at 37°C, the result being a slower release of the antigen. There is not space here to record the many combinations that could be used; the preparation of a pure sample of phosphatidylcholine (ovo-lecithin) and positively and negatively charged liposomes will be given as examples.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gregoriadis, G. (1988) Fate of injected liposomes: observations on entrapped solute retention, vesicle clearance and tissue distribution in vivo, in Liposomes as Drug Carriers Recent Trends and Progress (Gregoriadis, G., ed.), Wiley, Chichester and New York, pp. 3–18.
van Rooijen, N. and Su, D. (1989) Immunoadjuvant action of liposomes: mechanisms, in Immunological Adjuvants and Vaccines (Gregoriadis, G., Allison, A. C. and Poste, G., eds.), Plenum, New York, pp. 95–106.
Stewart-Tull, D. E. S., Davies, M, and Jackson, D. M. (1978) The binding of adjuvant-active mycobacterial peptidoglycolipids and glycopeptides to mammalian membranes and their effect on artificial lipid bilayers. Immunology 34, 57–67
Davies, M., Stewart-Tull, D. E. S., and Jackson, D. M. (1978) The binding of lipopolysaccharide from Eschenchia coli to mammalian cell membranes and its effect on liposomes. Biochim Biophys Acta 508, 260–276.
Pangborn, M. (1951) A simplified purification of lecithin. J. Biol. Chem. 188, 471–476.
Gregoriadis, G (1989) Liposomes as immunological adjuvants, in The Theory and Practical Application of Adjuvants (Stewart-Tull, D. E. S., ed.), Wiley, Chichester and New York, pp. 143–169.
Gregoriadrs, G., Tan, L, and Xiao, Q. (1989) The immunoadjuvant action of liposomes: role of structural characteristics, in Immunological Adjuvants and Vaccines (Gregoriadis, G., Allison, A. C., and Poste, G., eds.), Plenum, New York, pp. 79–94.
Gregoriadis, G., Davis, D., and Davies, A. (1987) Liposomes as immunological adjuvants in vaccines: antigen incorporation studies. Vaccine 5, 145–151.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Humana Press Inc, Totowa, NJ
About this protocol
Cite this protocol
Stewart-Tull, D.E.S. (1996). The Use of Adjuvants in Experimental Vaccines. In: Robinson, A., Farrar, G.H., Wiblin, C.N. (eds) Vaccine Protocols. Methods in Molecular Medicine™, vol 4. Humana Press. https://doi.org/10.1385/0-89603-334-1:147
Download citation
DOI: https://doi.org/10.1385/0-89603-334-1:147
Publisher Name: Humana Press
Print ISBN: 978-0-89603-334-4
Online ISBN: 978-1-59259-588-4
eBook Packages: Springer Protocols